Juul Settles with Iowa Over Underage Marketing

Dec.29.2022
Juul Settles with Iowa Over Underage Marketing
Juul, a major US e-cigarette manufacturer, will pay $5m and improve its advertising to settle claims of targeting minors in Iowa.

Juul, the largest electronic cigarette manufacturer in the United States, has agreed to improve its advertising and retail practices in Iowa and pay $5 million over the course of four years to resolve allegations of violating state laws.


Iowa's Attorney General Tom Miller announced a settlement with Juul to resolve potential violations of Iowa's Deceptive Trade Practices Act.


Miller claims that targeting individuals under the age of 21 in Iowa is a violation of state law, and is a focus of their company's products.


In a statement, Miller said, "The agreement strikes a balance in the truthful advertising and promotion of Juul e-cigarette devices and pods. E-cigarettes should be marketed to smokers as a less harmful alternative, but not to young people.


As part of an agreement, Juul has agreed to annually send $1.25 million to the Iowa Department of Public Health. The funds will be used to provide resources and education to youth under the age of 21 in Iowa, including assistance with smoking cessation.


The company denies any wrongdoing and additionally agrees to: [insert other terms here].


Do not target young people in Iowa through advertising, promotions, or marketing of Juul products.


Individuals are required to conduct age verification on any website they own or operate.


Do not display Juul products in retail stores outside of the counter area, and customers are not allowed to access the products with the assistance of employees.


Online transactions will be limited to a maximum of two Juul devices per month, ten Juul devices per year, and 60 Juul pods per month.


Taking reasonable measures, retail transactions in Iowa are limited to one Juul device or 16 Juul pods per transaction.


Do not sell products to consumers under the age of 21.


Disclose the nicotine content in their products.


The company has also agreed to appoint a designated staff member to ensure compliance with the agreement with the Iowa Attorney General's office and to address any compliance-related issues.


In 2018, Juul Labs sought guidance from Miller on using their product as a means to reach young people. Miller was employed as part of these efforts.


In April 2018, this electronic cigarette manufacturer announced that, as part of a $30 million initiative over the next three years, it will support efforts by states and the federal government to raise the minimum age for purchasing tobacco products. The initiative amounts to approximately 210 million yuan.


Part of the funding includes a research team led by former Attorney General and public health officials, convened by Miller, who has ties to the tobacco industry.


A spokesperson for the Office of the Attorney General stated, "The consulting group was independent from Juul, and its members did not receive any form of compensation. The group's recommendations to Juul were similar to the final settlement agreement. The consulting group disbanded at the end of 2018.


In 1998, Miller and other 45 state attorneys general signed a settlement agreement with the four major tobacco companies in the United States to resolve lawsuits related to state healthcare costs associated with smoking-related illnesses.


This agreement is the largest of its kind in American history, requiring companies to pay $206 billion over 25 years to 46 states, followed by annual payments based on national cigarette sales.


Over the past 24 years, the state has received more than $1.41 billion (approximately RMB 9.84 billion) in payments as part of the peace agreement.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | Summo 150K Introduces Refillable Design With Up to 150,000 Puffs, Exploring a New High-Capacity Vape Format
Product | Summo 150K Introduces Refillable Design With Up to 150,000 Puffs, Exploring a New High-Capacity Vape Format
Summo has introduced the Summo 150K Refillable Disposable Vape, entering the ultra-high-puff vape segment with a claimed capacity of up to 150,000 puffs. The device combines a 40ml dual e-liquid system, transparent tank design, dual mesh coils and a 900mAh rechargeable battery, using a refillable structure to differentiate itself from conventional disposable vapes. The product appeared on overseas online retail channels including Vapesourcing and VapeBarTime between late June and early July 2026.
Jul.22
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
China Tobacco Supply-Chain Leader Huabao’s Three-Way Transformation Takes Hold as Overseas Revenue Jumps 216%, Non-Flavor Businesses Reach 42.2% and the Company Expands Into Global Next-Generation Tobacco Supply Chains
Huabao’s H1 2026 results show the company advancing across three connected fronts: international expansion, entry into next-generation tobacco supply chains and diversification beyond its traditional tobacco-related base. Overseas revenue rose 216.08% to CNY 96.02 million, while non-flavor businesses reached 42.2% of total revenue. Huabao also said it had entered the supply chains of leading global tobacco customers, as its nutrition, food ingredient, fragrance and personal-care businesses gained ground in Europe, Southeast Asia, Australia and New Zealand. However, adjusted net profit increased only 2.78%, and next-generation tobacco revenue was not separately disclosed, showing that the transformation is reshaping revenue and customer exposure but has yet to translate fully into underlying earnings.
Aug.28
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
BAT Expands ITC Infotech Partnership Across Poland, Romania and India to Advance AI
ITC Infotech has expanded its multi-year strategic technology partnership with British American Tobacco (BAT), providing technology services across Poland, Romania and India while continuing to support BAT's newly launched Future Capabilities Centre in India and existing technology hubs in Malaysia and Mexico. The companies said the agreement will focus on AI-enabled innovation, technology capability building and greater operational efficiency. The partnership also aligns with BAT's broader Fit2Win transformation programme, under which the group is expanding the use of external technology and business-services partners to simplify its global operating model.
Aug.13
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA Issues First U.S. Clinical Guidance on Vaping for Smoking Cessation, Urging Complete Switch From Cigarettes
JAMA has published a Special Communication offering systematic recommendations for U.S.-based clinicians on the use of nicotine e-cigarettes in adult smoking cessation. Developed by the Harm Reduction Workgroup of the Society for Research on Nicotine and Tobacco’s Treatment Research Network, the paper recommends including e-cigarettes alongside FDA-approved cessation medications in risk-benefit discussions. It cites high-certainty evidence that nicotine e-cigarettes achieve higher quit rates than nicotine replacement therapy and evidence suggesting efficacy comparable to highly effective medications such as varenicline and cytisine. For adults who choose vaping to quit, the authors recommend FDA-authorized products, sufficient nicotine delivery and a rapid, complete transition away from cigarettes rather than prolonged dual use.
Aug.13
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Drug Regulator Target Illegal Vape Sales Disguised as Medical Devices, Define Six Violations
China’s Jiangsu Tobacco Monopoly Bureau and Jiangsu Provincial Medical Products Administration have issued a joint notice targeting illegal production and sales of vape products disguised as medical devices. The notice identifies six categories of violations, including obtaining medical licenses through false materials, misusing medical device credentials, expanding production beyond approved scopes, and using medical device-related online platforms to promote or sell vape products. The action is based on China’s tobacco and medical device regulations and aims to strengthen vape oversight and consumer protection.
Aug.04
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
Australian Coalition Taskforce Calls for 80% Tobacco Tax Cut to Combat Illicit Market
According to SGST on August 26, 2026, Australia’s Coalition Illegal Tobacco Taskforce released a report recommending an up to 80% cut in tobacco excise to reduce the appeal of the illicit tobacco market. The report claimed organised crime groups now control about 80% of Australia’s tobacco market and argued that high excise rates have widened the price gap between legal and illegal products. The recommendation remains a policy proposal and has not been adopted by the Australian government, which said its focus remains on enforcement, compliance and additional resources.
Aug.27